Appendix 4E and Financial Report
Filed with ASX · · 70 pages · English
Earlier from PainChek
- PainChek receives $1.123 million R&D tax incentive refund
- US MedTech leader Karen Holzberger appointed CEO
- CEO Transition
- PainChek secures A$5.5m note to fund US expansion
- Landmark Sabra North America deployment targeting 20k beds
Later from PainChek
- PainChek expands Sabra contracts to 23 US communities
- PainChek wins 1,800-licence UK contract with Hallmark
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow PainChek into a list and get an email when it puts out news.
Follow PainChek